Department of Pathology, Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Gastroenterology and Hepatology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Bioengineered. 2022 Mar;13(3):5880-5891. doi: 10.1080/21655979.2022.2040875.
To observe the role of transforming growth factor beta-activated kinase 1 (TAK1)/p38 MAPK/TGF-β1 signal pathway plays in oxidative stress and apoptosis in human renal tubular epithelial cells (HK-2) under high glucose induction. HK-2 cells were cultured in high glucose medium with and without TAK1 inhibitor 5Z-7-oxozeaenol. TUNEL and flow cytometry were used to detect cell apoptosis. The protein expression of TAK1, TGF-β1, Bax and Bcl-2 was detected by immunofluorescence. Meanwhile, flow cytometry was used to detect the production of reactive oxygen species (ROS), and MitoSOX staining was performed to detect the production of mitochondrial ROS. Moreover, real-time quantitative PCR and Western blotting was used to measure the expression of TAK1, TGF-β1, NOX1, NOX4 and HO-1, Bax, Bcl-2, p38MAPK, p-p38MAPK and TGF-β1. Results showed that high glucose up-regulated the protein expression of p-TAK1, p-p38 MAPK and TGF-β1, which induced the aggravation of oxidative stress by promoting the production of ROS, thus promote the apoptosis in HK-2 cells. However, addition of 5z -7-oxozeaenol in HK-2 cells reversed all the above functions induced by high glucose. Another experimental result also showed that SB203580, a p38MAPK inhibitor can down-regulated TGF-β1 expression and reduce ROS production, thus alleviate cell apoptosis in TAK1 overexpression group. In summary, high glucose intervention could activate TAK1 and promote apoptosis in HK-2 cells. Inhibition of TAK1 expression could block p38 MAPK/TGF-β1 signaling pathway and reduce ROS production and oxidative stress, which may be one of the signal pathways of TAK1 to reduce apoptosis of HK-2 cells induced by high glucose.: DN, Diabetic nephropathy; TAK1, transforming growth factor β-activated kinase-1; TGF-β, transforming growth factor-β; NG, normal glucose; HG, high glucose; p38 MAPK, p38 mitogen-activated protein kinase; ROS, reactive oxygen species.
观察转化生长因子β激活激酶 1(TAK1)/p38MAPK/TGF-β1 信号通路在高糖诱导下人肾小管上皮细胞(HK-2)氧化应激和凋亡中的作用。将 HK-2 细胞在高糖培养基中培养,同时加入和不加入 TAK1 抑制剂 5Z-7-氧杂嗪醇。用 TUNEL 和流式细胞术检测细胞凋亡。用免疫荧光法检测 TAK1、TGF-β1、Bax 和 Bcl-2 的蛋白表达。同时,用流式细胞术检测活性氧(ROS)的产生,用 MitoSOX 染色检测线粒体 ROS 的产生。此外,用实时定量 PCR 和 Western blot 法检测 TAK1、TGF-β1、NOX1、NOX4 和 HO-1、Bax、Bcl-2、p38MAPK、p-p38MAPK 和 TGF-β1 的表达。结果表明,高糖上调了 p-TAK1、p-p38MAPK 和 TGF-β1 的蛋白表达,通过促进 ROS 的产生,加重氧化应激,从而促进 HK-2 细胞凋亡。然而,在 HK-2 细胞中加入 5Z-7-氧杂嗪醇可逆转高糖诱导的所有上述功能。另一个实验结果还表明,p38MAPK 抑制剂 SB203580 可下调 TGF-β1 的表达,减少 ROS 的产生,从而减轻 TAK1 过表达组细胞凋亡。综上所述,高糖干预可激活 TAK1,促进 HK-2 细胞凋亡。抑制 TAK1 的表达可阻断 p38MAPK/TGF-β1 信号通路,减少 ROS 的产生和氧化应激,这可能是 TAK1 减少高糖诱导的 HK-2 细胞凋亡的信号通路之一。